Valeris, Inc.

Valeris is a privately held, fully integrated life sciences commercialization partner dedicated to enhancing patient lives by streamlining access and adherence to critical medications. Formed in May 2025 through the merger of Mercalis and PharmaCord, the company provides comprehensive solutions across the entire healthcare value chain. Valeris maintains dual headquarters in Morrisville, North Carolina, and Jeffersonville, Indiana.

The company's core offerings include data and strategic insights, patient support services, and healthcare provider engagement tools. Valeris's services encompass patient access and affordability programs, non-commercial dispensing pharmacy services, nursing support services, patient engagement and adherence solutions, and the Valeris eServices Curator. These solutions are designed to support biopharma companies from pre-launch through long-term commercialization, addressing challenges in patient access, affordability, and engagement.

In recent news, Valeris launched Valeris Vantage™, an Operational Intelligence Platform, in June 2026 to provide real-time guidance and data insights for patient support teams. The company also appointed Scott Filosi as Chief Commercial Officer in April 2026. Led by CEO Rob Truckenmiller and President Scott Dulitz, Valeris reported strong fiscal year 2025 results in January 2026, marked by significant growth and successful integration milestones, solidifying its position as a leading US Market Access and Patient Services partner.